# Clinical Research of TCM on Pelvic Inflammatory Disease Sequelae

> **NCT02972151** · PHASE2 · UNKNOWN · sponsor: **Shanghai University of Traditional Chinese Medicine** · enrollment: 175 (estimated)

## Conditions studied

- Pelvic Inflammatory Disease

## Interventions

- **DRUG:** Comprehensive treatment of TCM
- **OTHER:** Expectant treatment

## Key facts

- **NCT ID:** NCT02972151
- **Lead sponsor:** Shanghai University of Traditional Chinese Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-11
- **Primary completion:** 2018-12
- **Final completion:** 2018-12
- **Target enrollment:** 175 (ESTIMATED)
- **Last updated:** 2016-11-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02972151

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02972151, "Clinical Research of TCM on Pelvic Inflammatory Disease Sequelae". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02972151. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*